Antibiotic resistance and single-nucleotide polymorphism cluster grouping type in a multinational sample of resistant Mycobacterium tuberculosis isolates

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 4157-4159

  Brimacombe, M ^a   Hazbon, M ^a   Motiwala, A S ^a   Alland, D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CODON; GENE; GENE CLUSTER; GENE MUTATION; HUMAN; INTERNATIONAL COOPERATION; KATG GENE; MOLECULAR EVOLUTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM BASED CLUSTER GROUPING;

BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CATALASE; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 35848955465     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00619-07     Document Type: Article

References (26)

1. Abebe, F., and G. Bjune. 2006. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link? Clin. Exp. Immunol. 145:389-397.
2. Alland, D., G. E. Kalkut, A. R. Moss, R. A. McAdam, J. A. Hahn, W. Bosworth, E. Drucker, and B. R. Bloom. 1994. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N. Engl. J. Med. 330:1710-1716.
3. Alland, D., D. W. Lacher, M. H. Hazbón, A. S. Motiwala, W. Qi, R. D. Fleischmann, and T. S. Whittam. 2007. Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysis. J. Clin. Microbiol. 45:39-46.
4. Alland, D., T. S. Whittam, M. B. Murray, M. D. Cave, M. H. Hazbón, K. Dix, M. Kokoris, A. Duesterhoeft, J. A. Eisen, C. M. Fraser, and R. D. Fleischmann. 2003. Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis. J. Bacteriol. 185:3392-3399.
5. Aristimuno L., R. Armengol, A. Cebollada, M. Espana, A. Guilarte, C. Lafoz, M. A. Lezcano, M. J. Revillo, C. Martin, C. Ramirez, N. Rastogi, J. Rojas, A. V. de Salas, C. Sola, and S. Samper. 2006. Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Antituberculosis Drug Resistance from Venezuela. BMC Microbiol. 6:90.
6. Cox, H. S., T. Kubica, D. Doshetov, Y. Kebede, S. Rusch-Gerdess, and S. Niemann. 2005. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir. Res. 6:134.
7. Fang, Z., C. Doig, A. Rayner, D. T. Kenna, B. Watt, and K. J. Forbes. 1999. Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997). J. Clin. Microbiol. 37:998-1003.
8. Filliol, I., A. S. Motiwala, M. Cavatore, W. Qi, M. H. Hazbón, M. Bobadilla del Valle, J. Fyfe, L. Garcia-Garcia, N. Rastogi, C. Sola, T. Zozio, M. I. Guerrero, C. I. León, J. Crabtree, S. Angiuoli, K. D. Eisenach, R. Durmaz, M. L. Joloba, A. Rendón, J. Sifuentes-Osornio, A. Ponce de Leon, M. D. Cave, R. Fleischmann, T. S. Whittam, and D. Alland. 2006. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J. Bacteriol. 188:759-772.
9. Hazbón, M. H., and D. Alland. 2004. Hairpin primers for simplified single-nucleotide polymorphism analysis of Mycobacterium tuberculosis and other organisms. J. Clin. Microbiol. 42:1236-1242.
10. Hazbón, M. H., M. Bobadilla del Valle, M. I. Guerrero, M. Varma-Basil, I. Filliol, M. Cavatore, R. Colangeli, H. Safi, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, A. Davidow, M. Brimacombe, C. I. Leon, T. Porras, M. Bose, F. Chaves, K. D. Eisenach, J. Sifuentes-Osornio, A. Ponce de Leon, M. D. Cave, and D. Alland. 2005. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49:3794-3802.
11. Hazbón, M. H., M. Brimacombe, M. Bobadilla del Valle, M. Cavatore, M. I. Guerrero, M. Varma-Basil, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. García-García, C. Inés León, M. Bose, F. Chaves, M. Murray, K. D. Eisenach, J. Sifuentes-Osornio, M. D. Cave, A. Ponce de León, and D. Alland. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50:2640-2649.
12. Ignatova, A., S. Dubiley, V. Stepanshina, and I. Shemyakin. 2006. Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. J. Med. Microbiol. 55:1413-1418.
13. Kapetanaki, S. M., S. Chouchane, S. Yu, X. Zhao, R. S. Magliozzo, and J. P. Schelvis. 2005. Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function. Biochemistry 44:243-252.
14. Musser, J. M., V. Kapur, D. L. Williams, B. N. Kreiswirth, D. van Soolingen, and J. D. van Embden. 1996. Characterization of the catalase-peroxidasc gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202.
15. Pheiffer, C., J. C. Betts, H. R. Flynn, P. T. Lukey, and P. van Helden. 2005. Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv. Microbiology 151:1139-1150.
16. Pym, A. S., B. Saint-Joanis, and S. T. Cole. 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 70:4955-4960.
17. Ramaswamy, S. V., S. J. Dou, A. Rendon, Z. Yang, M. D. Cave, and E. A. Graviss. 2004. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J. Med. Microbiol. 53:107-113.
18. Ramazanzadeh, R., P. Farnia, N. N. Amirmozafari, F. Ghazi, Z. Ghadertotonchi, J. Kamran, F. Mohammadi, M. Mirsaedi, and M. Masjedi. 2006. Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients. Chemotherapy 52:316-320.
19. Saint-Joanis, B., H. Souchon, M. Wilming, K. Johnsson, P. M. Alzari, and S. T. Cole. 1999. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem. J. 338:753-760.
20. Sherman, D. R., K. Mdluli, M. J. Hickey, T. M. Arain, S. L. Morris, C. E. Barry III, and C. K. Stover. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272:1641-1643.
21. Sivkov, A. I., A. N. Boldyrev, M. S. Azaev, S. A. Bodnev, E. V. Medvedeva, O. I. Baranova, A. P. Ivlev-Dantau, L. N. Blinova, A. D. Pasechnikov, and S. I. Tat'kov. 2006. Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates. Mol. Gen. Mikrobiol. Virusol. 2006:20-25.
22. van Soolingen, D., P. E. de Haas, H. R. van Doorn, E. Kuijper, H. Rinder, and M. W. Borgdorff. 2000. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in The Netherlands. J. Infect. Dis. 182:1788-1790.
23. + ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob. Agents Chemother. 49:708-720.
24. Weis, S. E., J. M. Pogoda, Z. Yang, M. D. Cave, C. Wallace, M. Kelley, and P. F. Barnes. 2002. Transmission dynamics of tuberculosis in Tarrant County, Texas. Am. J. Respir. Crit. Care Med. 166:36-42.
25. Wilson, R. W., Z. Yang, M. Kelley, M. D. Cave, J. M. Pogoda, R. J. Wallace, Jr., J. P. Cegielski, D. F. Dunbar, D. Bergmire-Sweat, L. B. Elliott, and P. F. Barnes. 1999. Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in Texas. J. Clin. Microbiol. 37:3255-3259.
26. Wilson, T. M., and D. M. Collins. 1996. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol. Microbiol. 19:1025-1034.